IAM
BSX icon

Innovis Asset Management’s Boston Scientific BSX Stock Holding History

Innovis Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$7.22M Buy
136,755
+30,710
+29% +$1.61M 2.78% 11
2023
Q2 		$5.74M Buy
106,045
+30,340
+40% +$1.58M 2.12% 18
2023
Q1 		$3.79M Buy
75,705
+23,655
+45% +$1.11M 1.54% 23
2022
Q4 		$2.41M Buy
+52,050
New +$2.25M 1.09% 27

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Innovis Asset Management's BSX Position: Q3 2023 in Review

Innovis Asset Management increased its Boston Scientific (BSX) stake by 29% in Q3 2023, buying an estimated $1.61M and bringing the position to 136,755 shares worth $7.22M. The position accounts for 2.78% of the portfolio, ranked #11.

Innovis Asset Management first reported a position in BSX in Q4 2022 and has held it in 4 quarters since. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Innovis Asset Management held 136,755 shares of Boston Scientific worth $7.22M as of Q3 2023.
  • Innovis Asset Management bought 30,710 Boston Scientific shares in Q3 2023, an estimated $1.61M.
  • Boston Scientific made up 2.78% of Innovis Asset Management's portfolio in Q3 2023, its #11 holding.
  • Innovis Asset Management first reported a position in Boston Scientific in Q4 2022 and has held it in 4 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.